Saliva-based Screening Market is expected to reach a valuation of nearly $ 643 million with an 8% CAGR by the year 2031Posted by Steve Sharma on June 28th, 2022 Saliva Screening Market 2022 The global saliva-based screening market is estimated to reach US $ 643 million with an 8% CAGR by 2031 . With remote monitoring comes remote surgery. With digital twinning, this intervention becomes feasible. This could help save on complex medical product development prices, thus improvising the time-to-market metric. This would be the thing with the healthcare sector in the coming period. According to the latest industry analysis from Persistence Market Research, the global saliva-based screening market was valued at $ 277 million in 2020 and is expected to show an 8% CAGR over the forecast period 2021-2031. Rapidly developing technology in point-of-care testing is driving demand for saliva-based screening. There has been rapid growth in the adoption of saliva as a diagnostic sample over the past few decades. There have been important advances, including the application of saliva as a clinically relevant sample. The advent of new and more sensitive technologies for detecting minimal concentrations of analytes in saliva and the upward search in saliva-based genomics and proteomics has been witnessed over the years. Click Here To Get A Free Sample Copy Of This Report @ https://www.persistencemarketresearch.com/samples/32714 The availability of improved saliva collection devices is one example: RNAPro.SAL - Split Sample Kit for Liquid Biopsy, Pure.SAL (Oasis Diagnostics), Salivabio Oral Swab (SOS) (Salimetrics) and SDNA Saliva Collection Devices - IVD Molecular Diagnostic Testing (Spectrum Solutions LLC). Therefore, the availability of a safe, simple and non-invasive method for collecting samples offers profitable growth opportunities for market players. Although serum-based testing remains the gold standard for detecting HIV infections, saliva-based HIV screening has been widely used to diagnose disease in recent years. Oral mucosal transudate (OMT), which is found by swabbing the tongue and buccal mucosa, contains a mixture of antibodies to the immunoglobulin isotypes IgG, IgA, and IgM. Therefore, the easy availability of HIV antibodies in human saliva and the reduced risk of infection make saliva-based screening a preferred choice for HIV testing. In addition, real-time results, shorter turnaround times, the availability of diagnostic tests for HIV testing at home and the ease of sample collection are expected for a broader population base, particularly in emerging economies. development, will increase the adoption of saliva-based tests for HIV diagnosis. Customization Request @ https://www.persistencemarketresearch.com/request-customization/32714 Major market players are focusing on expanding their product portfolios through acquisitions and collaborations.
Key points of the market study
“The growing adoption of saliva-based screening, the growing demand for self-test / at-home saliva-based screening and growing technological advances are expected to boost market growth in the coming years,” says an analyst with Persistence Market Research. Click Here To Get This Report @ https://www.persistencemarketresearch.com/checkout/32714 Market competition Mergers, acquisitions and expansion of manufacturing facilities around the world are expected to introduce new opportunities to the market. The introduction of new products with greater sensitivity and specificity will be able to exploit untapped market opportunities. In addition, manufacturers are involved in research and development activities for the application of saliva-based screening in various research applications. Who we are: Persistence Market Research (PMR), as a third-party research organization, works through a unique fusion of market research and data analytics to help companies rise to the top, regardless of the turmoil faced due to financial / natural crises. Contact us: Persistence Market Research Like it? Share it! More by this author |